NVRO

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Nevro Corp

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.
CEO
D.Keith Grossman
Employees
843
Headquarters

1800 Bridge Pkwy
Redwood City, California 94065-1164
Phone: 16502510005
www.nevro.com

News

Nevro Corp PT Raised to $45 at Truist Securities Following Meetings with CFO Rod MacLeod
Nov 18, 2022 17:35pm

https://www.investing.com/news/pro/nevro-corp-pt-raised-to-45-at-truist-securities-following-meetings-with-cfo-rod-macleod-432SI-2948128


Source:Investing.com
Analysts Say That Nevro Corp. (NYSE:NVRO) Is Likely To Make It To $75.00 In 12 Months
Nov 04, 2022 12:30pm

In last trading session, Nevro Corp. (NYSE:NVRO) saw 1.82 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $41.69 trading at $4.99 or 13.60% at ring of the bell on the day assigns it a market valuation of $1.40B. That closing price of NVRO’s stock is at … Analysts Say That Nevro Corp. (NYSE:NVRO) Is Likely To Make It To $75.00 In 12 Months Read More »


Source:Marketing Sentinel
Nevro Corporation (NVRO) Q3 2022 Earnings Call Transcript
Nov 03, 2022 06:22am

Nevro Corporation (NYSE:NYSE:NVRO) Q3 2022 Earnings Conference Call November 02, 2022, 16:30 ET Company Participants Julie Dewey - Chief Corporate Communications & IR Officer Keith…


Source:Seeking Alpha
Nevro Corp. 2022 Q3 - Results - Earnings Call Presentation (NYSE:NVRO)
Nov 03, 2022 03:24am

The following slide deck was published by Nevro Corp.


Source:Seeking Alpha
Nevro Corp Earnings, Revenue Beat in Q3 By Investing.com
Nov 02, 2022 22:54pm

Nevro Corp Earnings, Revenue Beat in Q3


Source:Investing.com
Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy
Nov 02, 2022 20:05pm

REDWOOD CITY, Calif., Nov. 2, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its financial results for the third quarter ended September 30, 2022, narrowed its full-year 2022 guidance and…


Source:PR Newswire
Nevro Corp. (NVRO) deserves closer scrutiny
Nov 01, 2022 13:00pm

The share price of Nevro Corp. (NYSE:NVRO) fell to $38.34 per share on Monday from $38.84. While Nevro Corp. has underperformed by -1.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NVRO fell by -66.29%, with highs and lows ranging from $117.57 to $34.70, whereas the […]


Source:US Post News
NVRO stock lower as Boston Scientific cites sales pressures in neuromodulation (NYSE:NVRO)
Oct 26, 2022 17:43pm

Nevro Corp. (NVRO), a company focused on neuromodulation solutions, dropped at the open on Wednesday after its rival Boston Scientific (BSX) said that its Q3 sales for the pain…


Source:Seeking Alpha
Nevro Corp PT Lowered to $43 at Truist Securities
Oct 17, 2022 12:13pm

https://www.investing.com/news/pro/nevro-corp-pt-lowered-to-43-at-truist-securities-432SI-2913772


Source:Investing.com
Nevro Corp. (NYSE:NVRO) Shares Are Up 10.17% From The Lows, But Can They Stay Up?
Oct 15, 2022 12:00pm

In last trading session, Nevro Corp. (NYSE:NVRO) saw 0.79 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price level of $38.63 trading at $0.37 or 0.97% at ring of the bell on the day assigns it a market valuation of $1.54B. That closing price of NVRO’s stock is at … Nevro Corp. (NYSE:NVRO) Shares Are Up 10.17% From The Lows, But Can They Stay Up? Read More »


Source:Marketing Sentinel
Nevro''s Senza spinal cord stimulation system for chronic pain gets FDA approval
Oct 13, 2022 09:32am

The U.S. Food and Drug Administration ((FDA)) approved Nevro''s (NVRO) Senza HFX iQ spinal cord stimulation ((SCS)) system


Source:Seeking Alpha
Nevro plays down impact from UnitedHealth coverage decision
Oct 10, 2022 11:31am

Healthcare equipment maker Nevro Corp. (NVRO) announced Monday that the recent decision by UnitedHealthcare (UNH) to limit coverage for spinal cord stimulation ((SCS)) devices is…


Source:Seeking Alpha
Investing in Nevro Corp. (NVRO) might be an excellent idea, but the stock is currently overvalued/undervalued
Oct 07, 2022 13:48pm

A share of Nevro Corp. (NYSE:NVRO) closed at $43.51 per share on Thursday, down from $49.13 day before. While Nevro Corp. has underperformed by -11.44%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NVRO fell by -63.22%, with highs and lows ranging from $121.78 to $39.41, […]


Source:US Post News
United Health''s Policy Change "A Drag on Nevro''s Underlying Business" - Truist Securities
Oct 06, 2022 19:46pm

https://www.investing.com/news/pro/united-healths-policy-change-a-drag-on-nevros-underlying-business--truist-securities-432SI-2906697


Source:Investing.com
Nevro down 9% after UnitedHealth won''t cover spinal cord stimulation for some indications
Oct 06, 2022 18:49pm

Nevro Corp. (NVRO) is down 8% in Thursday afternoon trading after UnitedHealth issued a new medical coverage determination for spinal cord stimulators that excludes coverage in some cases.


Source:Seeking Alpha
Nevro to Report Third Quarter 2022 Financial Results
Oct 05, 2022 11:00am

Company to Host Conference Call on Wednesday, November 2, 2022 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif., Oct. 5, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic…


Source:PR Newswire
Nevro gets FDA approval for Costa Rica manufacturing operations (NYSE:NVRO)
Oct 04, 2022 20:25pm

Medical device company Nevro (NVRO) on Tuesday said the U.S. FDA had approved its manufacturing operations in Costa Rica


Source:Seeking Alpha
Nevro Announces FDA Approval of Costa Rica Manufacturing Operations
Oct 04, 2022 20:05pm

REDWOOD CITY, Calif., Oct. 4, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that the U.S. Food and Drug Administration (FDA) has approved its…


Source:PR Newswire
Voith torque limiting coupling with controlled slip
Sep 29, 2022 00:00am

SmartSet is a torque-limiting coupling with controlled slip based on the same technology as SafeSet, with the additional ability to also slip without releasing, to reduce the short duration and dynamic torque peaks without interrupting production. The SmartSet principle is simple: controlled slip torque for process improvement. The SmartSet coupling can safely slip up to […]


Source:WTWH